Pranoot Tanpaiboon - Concepedia

Author

Pranoot Tanpaiboon

Children's National ORCID

Also Known As

P Tanpaiboon, P. Tanpaiboon, Pasquale Martinelli, Pranoot Tanpaiboon, Pranoot X. Tanpaiboon, Zehra S. Arıcı

103

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

Children's National Chiang Mai University National Institutes of Health National Human Genome Research Institute University of Pittsburgh

About

Pranoot Tanpaiboon is an author at Children's National specializing in medicine, genetics, and autoimmune disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	357
2	Biochemistry	2	2	27
3	Health Sciences	1	1	17
4	Natural Sciences	1	1	10
5	Public Health	1	1	22

Pranoot Tanpaiboon

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
Gray platelet syndrome: natural history of a large patient cohort and locus assignment to chromosome 3p Meral Gunay‐Aygun, Yifat Zivony-Elboum, Fatma Gümrük, Blood	2010	153
Noonan syndrome in diverse populations Paul Kruszka, Antonio R. Porras, Yonit A. Addissie, American Journal of Medical Genetics Part A	2017	89
UX007 for the treatment of long chain-fatty acid oxidation disorders: Safety and efficacy in children and adults following 24 weeks of treatment Jerry Vockley, Barbara K. Burton, Gerard T. Berry, Molecular Genetics and Metabolism	2017	78
Sustained immune tolerance induction in enzyme replacement therapy–treated CRIM-negative patients with infantile Pompe disease Zoheb B. Kazi, Ankit K. Desai, Kathryn L. Berrier, JCI Insight	2017	68
Results from a 78‐week, single‐arm, open‐label phase 2 study to evaluate UX007 in pediatric and adult patients with severe long‐chain fatty acid oxidation disorders (LC‐FAOD) Jerry Vockley, Barbara K. Burton, Gerard T. Berry, Journal of Inherited Metabolic Disease ObesityMetabolic SyndromeOpen‐label Phase 2Heart FailureSevere Lc-faod	2019	59
Transforming the clinical outcome in CRIM-negative infantile Pompe disease identified via newborn screening: the benefits of early treatment with enzyme replacement therapy and immune tolerance induction Cindy Li, Ankit K. Desai, Punita Gupta, Genetics in Medicine Maternal ImmunizationNewborn ScreeningAutoimmune DiseaseEnzyme Replacement TherapyImmunodeficiencies	2021	56
Novel Variant Findings and Challenges Associated With the Clinical Integration of Genomic Testing Jill L. Maron, Stephen F. Kingsmore, Kristen Wigby, JAMA Pediatrics	2021	55
Effects of triheptanoin (<scp>UX007</scp>) in patients with long‐chain fatty acid oxidation disorders: Results from an <scp>open‐label</scp>, <scp>long‐term</scp> extension study Jerry Vockley, Barbara K. Burton, Gerard T. Berry, Journal of Inherited Metabolic Disease	2020	54
Cornelia de Lange syndrome in diverse populations Leah Dowsett, Antonio R. Porras, Paul Kruszka, American Journal of Medical Genetics Part A Autoimmune DiseaseOphthalmologySclerodermaUpper Limb AnomaliesLange Syndrome	2019	53
Mucopolysaccharidosis IVA (Morquio A syndrome) and VI (Maroteaux–Lamy syndrome): under-recognized and challenging to diagnose Ralph S. Lachman, Barbara K. Burton, L. Clarke, Skeletal Radiology	2014	50

Page 1